Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (21-30 of 266) with videos related to

Pageof 27
Sort By:
BJU International|February 26, 2009
Current textbooks and anatomy of the prostate--a case for an updateNathan Lawrentschuk, Uri Lindner, Neil Fleshner
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2009
Brian Mayson, Neil Fleshner, Alan So
European Urology Focus|May 17, 2021
A Clinical Trial of Prophylactic Prostatectomy for BRCA2 Mutation Carriers: Is Now the Time?Roderick Clark, Kristen McAlpine, Neil Fleshner
The Canadian Journal of Urology|December 4, 2004
The role of bisphosphonates in the management of bone metastases in prostate cancerFred Saad, Kim Chi, Neil Fleshner
The Journal of Urology|June 6, 2019
Editorial CommentMadhur Nayan, Neil Fleshner, Anthony Bozzo
Current Opinion in Urology|July 20, 2022
The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriersRaj Tiwari, Roderick Clark, Neil Fleshner
BJU International|June 26, 2004
Publication rate of abstracts presented at the annual meeting of the American Urological AssociationLongena Ng, Karen Hersey, Neil Fleshner
Urology|May 11, 2005
Differences between urologists in United States and Canada in approach to bladder cancerDoreen Chung, Karen Hersey, Neil Fleshner
The Urologic Clinics of North America|May 9, 2007
Management of low-stage testicular seminomaMischel Neill, Padraig Warde, Neil Fleshner
The Canadian Journal of Urology|November 9, 2005
Remission of hormone-refractory prostate cancer attributed to EssiacWigdan Al-Sukhni, Ami Grunbaum, Neil Fleshner
Pageof 27

Showing results (21-30 of 266) with videos related to

Sort By:
Pageof 27
BJU International|February 26, 2009
Current textbooks and anatomy of the prostate--a case for an updateNathan Lawrentschuk, Uri Lindner, Neil Fleshner
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2009
Brian Mayson, Neil Fleshner, Alan So
European Urology Focus|May 17, 2021
A Clinical Trial of Prophylactic Prostatectomy for BRCA2 Mutation Carriers: Is Now the Time?Roderick Clark, Kristen McAlpine, Neil Fleshner
The Canadian Journal of Urology|December 4, 2004
The role of bisphosphonates in the management of bone metastases in prostate cancerFred Saad, Kim Chi, Neil Fleshner
The Journal of Urology|June 6, 2019
Editorial CommentMadhur Nayan, Neil Fleshner, Anthony Bozzo
Current Opinion in Urology|July 20, 2022
The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriersRaj Tiwari, Roderick Clark, Neil Fleshner
BJU International|June 26, 2004
Publication rate of abstracts presented at the annual meeting of the American Urological AssociationLongena Ng, Karen Hersey, Neil Fleshner
Urology|May 11, 2005
Differences between urologists in United States and Canada in approach to bladder cancerDoreen Chung, Karen Hersey, Neil Fleshner
The Urologic Clinics of North America|May 9, 2007
Management of low-stage testicular seminomaMischel Neill, Padraig Warde, Neil Fleshner
The Canadian Journal of Urology|November 9, 2005
Remission of hormone-refractory prostate cancer attributed to EssiacWigdan Al-Sukhni, Ami Grunbaum, Neil Fleshner
Pageof 27